• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解骨肉瘤。

Understanding osteosarcomas.

作者信息

Simpson Emily, Brown Heather L

机构信息

At the time this article was written, Emily Simpson was a student in the PA program at Mercer University in Atlanta, Ga. She now practices urgent care medicine with Georgia Emergency Associates in Savannah, Ga. Heather L. Brown is an adjunct assistant professor in the PA program at Mercer University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2018 Aug;31(8):15-19. doi: 10.1097/01.JAA.0000541477.24116.8d.

DOI:10.1097/01.JAA.0000541477.24116.8d
PMID:29979330
Abstract

This article reviews the cause, clinical presentation, diagnostic methods, and management of osteosarcoma, the most common primary bone tumor and third most common cancer among children and adolescents. In the 1970s, the introduction of adjuvant chemotherapy following tumor resection improved overall 10-year survival from 30% to about 50% of patients. However, since that change in management strategy, the survival rate has since plateaued, with no improvement in overall 10-year survival since the 1990s. A better understanding of this disease is the first step to help improve these numbers.

摘要

本文综述了骨肉瘤的病因、临床表现、诊断方法及治疗,骨肉瘤是儿童和青少年中最常见的原发性骨肿瘤,也是第三大常见癌症。20世纪70年代,肿瘤切除术后引入辅助化疗使患者的10年总生存率从30%提高到了约50%。然而,自管理策略发生这一变化以来,生存率一直处于平稳状态,自20世纪90年代以来,10年总生存率没有提高。更好地了解这种疾病是帮助改善这些数据的第一步。

相似文献

1
Understanding osteosarcomas.了解骨肉瘤。
JAAPA. 2018 Aug;31(8):15-19. doi: 10.1097/01.JAA.0000541477.24116.8d.
2
Osteosarcoma.骨肉瘤。
Ann Oncol. 2010 Oct;21 Suppl 7:vii320-5. doi: 10.1093/annonc/mdq276.
3
Osteosarcoma.骨肉瘤
Pediatr Clin North Am. 1997 Aug;44(4):973-89. doi: 10.1016/s0031-3955(05)70540-x.
4
Multidisciplinary approach to osteosarcoma.骨肉瘤的多学科治疗方法。
Acta Orthop Belg. 2016 Dec;82(4):690-698.
5
Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group.非常年幼儿童的骨肉瘤:合作骨肉瘤研究组的经验。
Cancer. 2010 Nov 15;116(22):5316-24. doi: 10.1002/cncr.25287.
6
Late recurrence of osteosarcoma: a report of two cases.骨肉瘤的晚期复发:两例报告
J Orthop Surg (Hong Kong). 2014 Dec;22(3):415-9. doi: 10.1177/230949901402200329.
7
Palliative therapy for osteosarcoma.骨肉瘤的姑息疗法。
Expert Rev Anticancer Ther. 2011 Feb;11(2):217-27. doi: 10.1586/era.10.172.
8
Biology and therapeutic advances for pediatric osteosarcoma.儿童骨肉瘤的生物学与治疗进展
Oncologist. 2004;9(4):422-41. doi: 10.1634/theoncologist.9-4-422.
9
Osteosarcomas and other cancers of bone.骨肉瘤及其他骨癌。
Curr Opin Oncol. 2000 Jul;12(4):330-6. doi: 10.1097/00001622-200007000-00009.
10
Novel insights and therapeutic interventions for pediatric osteosarcoma.小儿骨肉瘤的新见解与治疗干预措施
Future Oncol. 2017 Feb;13(4):357-368. doi: 10.2217/fon-2016-0261. Epub 2016 Sep 21.

引用本文的文献

1
PSAT1 inhibits ferroptosis in osteosarcoma cells by activating the Xct/GPX4 signaling axis.PSAT1通过激活Xct/GPX4信号轴抑制骨肉瘤细胞中的铁死亡。
Sci Rep. 2025 Jul 21;15(1):26425. doi: 10.1038/s41598-025-09568-w.
2
Medicinal Plant-Derived Exosome-Like Nanovesicles as Regulatory Mediators in Microenvironment for Disease Treatment.药用植物来源的类外泌体纳米囊泡作为疾病治疗微环境中的调节介质
Int J Nanomedicine. 2025 Jun 30;20:8451-8479. doi: 10.2147/IJN.S526287. eCollection 2025.
3
Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi-Omics Analysis.
骨肉瘤中的外泌体基因生物标志物:多组学分析揭示米非司酮作为一种靶向治疗药物
FASEB J. 2025 Jul 15;39(13):e70809. doi: 10.1096/fj.202501151RR.
4
Elevated KIF2C Expression Drives Osteosarcoma Progression by Modulating the Wnt/β-Catenin Signaling Pathway and Contributing to an Immunosuppressive Tumor Microenvironment.KIF2C表达升高通过调节Wnt/β-连环蛋白信号通路并促成免疫抑制性肿瘤微环境来驱动骨肉瘤进展。
Cancer Med. 2025 May;14(9):e70915. doi: 10.1002/cam4.70915.
5
Unraveling the PANoptosis Landscape in Osteosarcoma: A Single-Cell Sequencing and Machine Learning Approach to Prognostic Modeling and Tumor Microenvironment Analysis.解析骨肉瘤中的PAN细胞焦亡全景:一种用于预后建模和肿瘤微环境分析的单细胞测序与机器学习方法
Int J Genomics. 2025 Mar 20;2025:6915258. doi: 10.1155/ijog/6915258. eCollection 2025.
6
Advancements in mesoporous bioactive glasses for effective bone cancer therapy: Recent developments and future perspectives.用于有效骨癌治疗的介孔生物活性玻璃的进展:最新进展与未来展望。
Biomater Biosyst. 2025 Feb 15;17:100108. doi: 10.1016/j.bbiosy.2025.100108. eCollection 2025 Mar.
7
The Role of Epithelial-Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy.上皮-间质转化在骨肉瘤进展中的作用:从生物学机制到治疗应用
Diagnostics (Basel). 2025 Mar 6;15(5):644. doi: 10.3390/diagnostics15050644.
8
Prognostic and Therapeutic Significance of Cancer-Associated Fibroblasts Genes in Osteosarcoma Based on Bulk and Single-Cell RNA Sequencing Data.基于批量和单细胞RNA测序数据的骨肉瘤中癌症相关成纤维细胞基因的预后和治疗意义
J Cell Mol Med. 2025 Mar;29(5):e70424. doi: 10.1111/jcmm.70424.
9
Clinical and Pathological Profile of Children and Adolescents with Osteosarcoma.骨肉瘤患儿及青少年的临床与病理特征
Diagnostics (Basel). 2025 Jan 23;15(3):266. doi: 10.3390/diagnostics15030266.
10
Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment.基于明胶的生物材料作为骨肉瘤治疗的递送策略。
Front Pharmacol. 2025 Jan 28;16:1537695. doi: 10.3389/fphar.2025.1537695. eCollection 2025.